Insider Stock Trading History of Campbell Bradley L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Campbell Bradley L since year 2005. The trader's CIK number is 1400971. At the time of this reporting, Campbell Bradley L is the Chief Operating Officer of Amicus Therapeutics Inc . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Campbell Bradley L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-03-02 FOLD Amicus Therapeutics Inc Sale 49,050 8.00 392,400
2017-01-03 FOLD Amicus Therapeutics Inc Option Ex 100,000 .00 0
2016-01-04 FOLD Amicus Therapeutics Inc Option Ex 50,000 .00 0
2015-09-21 FOLD Amicus Therapeutics Inc Option Ex 13,001 16.78 218,208
2015-09-21 FOLD Amicus Therapeutics Inc Sale 13,001 16.78 218,208
2015-06-19 FOLD Amicus Therapeutics Inc Option Ex 13,000 13.26 172,419
2015-06-19 FOLD Amicus Therapeutics Inc Sale 13,000 13.26 172,419
2015-05-08 FOLD Amicus Therapeutics Inc Option Ex 50,000 .00 0
2015-05-11 FOLD Amicus Therapeutics Inc Sale 24,800 10.84 268,807
2015-03-20 FOLD Amicus Therapeutics Inc Option Ex 12,999 11.51 149,592
2015-03-20 FOLD Amicus Therapeutics Inc Sale 12,999 11.51 149,592
2014-11-25 FOLD Amicus Therapeutics Inc Buy 7,250 8.00 58,000
2014-11-25 FOLD Amicus Therapeutics Inc Sale 7,250 8.00 58,000
2014-08-25 FOLD Amicus Therapeutics Inc Buy 7,000 6.00 42,000
2014-08-25 FOLD Amicus Therapeutics Inc Sale 7,000 6.00 42,000
2014-08-20 FOLD Amicus Therapeutics Inc Buy 18,750 5.40 101,250
2014-08-20 FOLD Amicus Therapeutics Inc Sale 18,750 5.40 101,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Campbell Bradley L (Chief Operating Officer of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.